急性胰腺炎乌司他丁治疗临床疗效研究.docVIP

急性胰腺炎乌司他丁治疗临床疗效研究.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
急性胰腺炎乌司他丁治疗临床疗效研究

急性胰腺炎乌司他丁治疗临床疗效研究   摘要:目的:分析急性胰腺炎乌司他丁治疗的临床疗效。方法:选取本院收治的60例急性胰腺炎临床资料,随机分为治疗组与对照组,各30例。对照组采取常规治疗,治疗组实施乌司他丁治疗,对比两组患者临床疗效。结果:治疗组总有效率为93.33%明显高于对照组的76.67%,差异有统计学意义(Plt;0.05)。治疗组腹痛缓解时间、胰腺水肿消失时间、首次主动排便时间均明显短于对照组,差异有统计学意义(Plt;0.05)。治疗组治疗后CRP、TNF-a、IL-15、IL-10等水平明显低于对照组,差异有统计学意义(Plt;0.05)。治疗组不良反应发生率为6.67%明显低于对照组的20.00%,差异有统计学意义(Plt;0.05)。结论:乌司他丁治疗急性胰腺炎,疗效安全,充分改善炎症因子水平,有效控制病情发展,降低不良反应发生率,值得临床推广。   关键词:急性胰腺炎 ;乌司他丁;临床疗效   Abstract: objective: to analysis the clinical curative effect of ulinastatin treatment of acute pancreatitis. Selection methods: clinical data of 60 patients admitted in our hospital with acute pancreatitis, randomly divided into treatment group and control group, 30 cases each. , control group treated with conventional treatment group implementation of ulinastatin treatment, compared two groups of patients with clinical efficacy. Results: treatment group total effective rate of 93.33% is significantly higher than the control group 76.67%, the difference was statistically significant (P lt; 0.05). Treatment group abdominal pain relief time, pancreatic edema disappeared, active for the first time defecation time were significantly shorter than the control group, the difference was statistically significant (P lt; 0.05). CRP, TNF - a group after treatment, IL - 15, IL - 10 levels significantly lower than the control group, the difference was statistically significant (P lt; 0.05). CRP, TNF - a group after treatment, IL - 15, IL - 10 levels significantly lower than the control group, the difference was statistically significant (P lt; 0.05). The incidence of adverse reactions was 6.67% treatment group was obviously less than 20.00% in the control group, the difference was statistically significant (P lt; 0.05). Conclusion: ulinastatin treatment of acute pancreatitis, curative effect of safety, fully improve the inflammatory factor levels, effective control of the disease, reduce the incidence of adverse reactions, worthy of clinical promotion.   Keywords: ac

文档评论(0)

189****7685 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档